Marken Expands Network In Africa And Middle East Region
Marken Operates in More African and Middle Eastern Countries than Any Other Provider
RESEARCH TRIANGLE PARK, North Carolina, June 15, 2016 /PRNewswire/ -- Marken announced today that their fully certified supply chain partner network in Africa and the Middle East now provides the most comprehensive and experienced time and temperature solutions in the region.
Logo - http://photos.prnewswire.com/prnh/20110930/NY78064LOGO
Africa and the Middle East continue as emerging preferred locations for new clinical trials because patients previously had limited options to quality healthcare. This diverse population of patients is now able to more easily enroll in clinical trials which are targeted for diseases prevalent in the region.
There is a further logistics benefit to sourcing patients in Africa. European pharma companies and their supply chains are in closer geographic proximity to Africa than Latin America. US-based pharma companies and their supply chains can benefit by supplementing patients in Africa over Asia. This expanding pool of new patients has translated into almost 12,000 active clinical trials running in 72 African and Middle Eastern countries including Egypt, Israel, Uganda, Jordan,and Kenya. *
Marken has a long and extensive experience in Africa and the Middle East. As a leader in the transport of biologic samples in the region, Marken has expanded its regulatory and compliance expertise to offer new services including drug and ancillaries shipments using the latest packaging innovations, state of the art GPS tracking, lane verification and risk mitigation to avoid catastrophe in countries with a still-developing infrastructure.
Wes Wheeler, Marken's Chief Executive Officer, noted, "Marken's dedicated team of Customs and Trade Compliance experts understand the regulatory requirements for every Health Ministry across the entire African continent and the Middle East. Clients tell us that they need Marken as their strategic partner to ensure a consistent level of performance, offer a single point of contact and, most importantly, to provide time and temperature compliant deliveries with reliable service. Marken has already managed nearly 3,000 shipments into the region this year, a 25% increase over 2015. We will continue to expand our reach and capabilities as the region evolves."
Marken is conducting a survey with a short series of questions regarding expanded supply chain solutions in Africa and the Middle East. Participants may share thoughts and provide valuable insight and suggest new services. To participate, visit www.marken.com and click on the survey link.
About Marken
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken's 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.
*Source: clinicaltrials.gov
Share this article